adjuvant, Adjuvant System, Alex Azar, Beijing Zhongguancun VC, Betta Capital, biotech innovation, Boris Johnson, Changxing China, Changxing Economic and Technological Development Zone, China, Clover Biopharmaceuticals, Coronavirus, COVID-19, Delos Capital, elderly, Eli Lilly, five-year plan, FlexFactory, Fujifilm Diosynth Biotech, GE, GE Healthcare, GE Healthcare Life Sciences, Gilead, GlaxoSmithKline, GSK, Guangyu Xu, Herd, herd immunity, Jinlong Group., Katrina, Lapam Capital, pandemic, pandemic containment, private equity firm, S-Trimer, Sichuan Clover Biopharmaceuticals, Sichuan Health Care Industry Fund, Tim Xiao, triage, Trimer-Tag, WHO, Wuhan, Wuhan Institute of Virology, Zhejiang
Sir Patrick Vallance, who is the UK’s Chief Scientific Advisor, was President of Research and Development at British Pharmaceutical Company GlaxoSmithKline (GSK) from 2012-17.
While the head of the World Health Organization asked countries to double down on containment, Vallance suggested that the “herd” of British citizens need to get the coronavirus, (even though that will mean the culling of (killing) more fragile members of the “herd” (public). His idea that this would confer immunity is unproven, as well. Meanwhile, some in Italy are apparently discussing triage-letting the elderly die, as one New Orleans hospital did during Hurricane Katrina.
GSK has recently partnered with a Chinese pharmaceutical company in an attempt to develop-test a vaccine. A “Principal” of Delos Capital sits on the board of the company, [Sichuan] Clover Biopharmaceuticals, since around the time Coronavirus (Covid-19) first “emerged” in Wuhan (home to the Wuhan Institute of Virology). It wasn’t reported to the World Health Organization until one month later. Delos is a private company located on 5th Avenue in NYC. They are but one investor.
“Clover and GSK announce research collaboration to evaluate coronavirus (COVID-19) vaccine candidate with pandemic adjuvant system, 24 February 2020 GSK will provide Clover with its pandemic adjuvant system for further evaluation of S-Trimer in preclinical studies…” https://archive.li/kuqFc
Various dates have been given for the first known Coronavirus (Covid-19) patient with the Chinese government saying it emerged on 17 November, which would be in line with symptoms starting on 1 December 2019 (another date given). Yet another date given was December 8, 2019. It was not reported to WHO until December 30th or 31st 2019. https://archive.li/xhFWD
Delos Capital is a Private Equity Firm located at 120 Fifth Ave, New York, NY.
On, or around, the date that the first case of Coronavirus (Covid-19) was reported in China, [Sichuan] Clover Biopharmaceuticals announced: “Clover Biopharmaceuticals Raises $43M in Series B Funding” Published on December 1, 2019 This round of capital funding was “led by Delos Capital and Lapam Capital, with participation from Betta Capital, Sichuan Health Care Industry Fund, Beijing Zhongguancun VC and Jinlong Group“. They announced that Mr. Tim Xiao, CFA, FRM, Principal of Delos Capital and Mr. Guangyu Xu, Partner of Lapam Capital would become members of Clover Biopharmaceuticals board of directors. http://archive.is/BJhAF
[Sichuan] Clover Biopharmaceuticals Biomanufacturing Facility, Changxing, China is a manufacturing facility located in Zhejiang, China that started construction in the second quarter of 2018. It is located in the Changxing Economic and Technological Development Zone (CETDZ) of Zhejiang, China. It is equipped with two 2,000l bioreactors provided by GE and operates on GE Healthcare’s manufacturing platform FlexFactory™. China’s most recent five-year plan focuses on biotech innovation with plans for 20 science parks for biomedicine by 2020. Clover uses a proprietary Trimer-Tag© technology. Companies involved in the project include GE Healthcare Life Sciences, glyXera, Fujifilm Diosynth Biotechnologies. See: “Clover Biopharmaceuticals Biomanufacturing Facility, Changxing, China“, Pharmaceutical Technology http://archive.is/naRhr
The head of WHO warns: “Let me be clear: describing this as a pandemic does not mean that countries should give up. The idea that countries should shift from containment to mitigation is wrong and dangerous. On the contrary, we have to double down. This is a controllable pandemic.” (WHO Director-General, 12 March 2020). WHO is a UN organization. The director general is Tedros Adhanom of Ethiopia and he is trying to save lives, unlike the former Pharma Exec Patrick Vallance: https://en.wikipedia.org/wiki/Tedros_Adhanom https://miningawareness.wordpress.com/2020/03/14/who-director-general-this-is-a-controllable-pandemic-countries-need-to-double-down-on-their-efforts-at-containment/
“Coronavirus: Experts cast doubt on UK plan for ‘herd immunity’: ‘We really don’t know whether there will be herd immunity or not,’ says head of virology at National Institute for Biological Standards and Control“, by Shaun Lintern Health Correspondent, March 13, 2020 https://www.independent.co.uk/news/health/coronavirus-herd-immunity-uk-covid-19-pandemic-outbreak-flu-a9400171.html
“Herd immunity: will the UK’s coronavirus strategy work?
Ministers look to have given up on containment in favour of a novel approach some experts are wary of ” https://www.theguardian.com/world/2020/mar/13/herd-immunity-will-the-uks-coronavirus-strategy-work
“As Europe Shuts Down, Britain Takes a Different, and Contentious, Approach, By Benjamin Mueller Published March 13, 2020 Updated March 14, 2020, 3:14 a.m. ET, New York Times: https://archive.li/JNgw6
“Critics slam UK PM Boris Johnson’s ‘gamble’ of allowing coronavirus to spread” By Bill Smith, March 13, 2020 https://www.iol.co.za/news/world/critics-slam-uk-pm-boris-johnsons-gamble-of-allowing-coronavirus-to-spread-44832452
According to Sir Patrick Vallance “the government was looking “to build up some kind of herd immunity so more people are immune to this disease and we reduce the transmission.”. Herd immunity, a term usually used to refer to the way mass vaccinations can stop the spread of disease and protect people who are not immune, is not seen by many scientists as a tool to be used against the coronavirus. Mr. Vallance has said that it would require roughly 60 percent of Britons to become infected, creating enough immunity in the population that a second surge in cases next winter would be less severe…” In stark contrast to Vallance, Helen Ward, Professor of public health at Imperial College London “said the government should consider making stronger recommendations to older people to cut back on their exposure. Mr. Johnson discouraged older Britons this week only from going on cruises, though many epidemiologists urge considerably stronger precautions.” (NYT, March 13, 2020: https://archive.li/JNgw6 )
Eoin Dineen @Eoin_Dineen wonders: “Why does delay phase in other countries involve social distancing and cancelling of mass gatherings, yet in the UK is based on 60% of population contracting it to supposedly build up herd immunity? Have I missed something?“3:14 PM – Mar 13, 2020
“From discovery to licensure, the Adjuvant System story“, by Nathalie Garçon and Alberta Di Pasquale https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287309/
“Clover and GSK Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with Pandemic Adjuvant System, Yahoo Finance- Business Wire February 24, 2020 GSK will provide Clover with its pandemic adjuvant system for further evaluation of S-Trimer in preclinical studies“. https://archive.li/lxrdK
“Clover Biopharmaceuticals Biomanufacturing Facility, Changxing, China“, by Pharmaceutical Technology http://archive.is/naRhr
“Chris Whitty, the chief medical officer, said that worst-case scenario planning projected that 80% of the country would contract the virus, with a 1% mortality rate. This equates to more than 500,000 deaths.” See: “Johnson: many more people will lose loved ones to coronavirus
Government says up to 10,000 may already be infected as UK moves into ‘delay’ phase” https://www.theguardian.com/world/2020/mar/12/uk-moves-to-delay-phase-of-coronavirus-plan
“The first COVID-19 case originated on November 17, according to Chinese officials searching for ‘Patient Zero’” MSN-Business Insider: https://archive.li/xhFWD
Members of Trump’s Coronavirus Task Force include former Eli Lilly CEO and biotech lobbyist, Secretary Alex Azar, Department of Health and Human Services and former lobbyist for Gilead, Joseph Grogan, Assistant to the President and Director of the Domestic Policy Council. https://archive.li/G3f5h
https://miningawareness.wordpress.com/2020/03/13/trump-admin-refusal-of-who-coronavirus-test-helped-create-more-human-guinea-pigs-for-gilead-sciences-other-pharma-biotech-cos If the US had already passed the Medicare for All bill, as written, by Bernie Sanders and Pramila Jayapal, the all important Secretary holding centralized control of US healthcare would be Alex Azar, former CEO of Eli Lilly & Company and former member of Biotechnology Innovation Organization, a pharmaceutical lobby. See: https://miningawareness.wordpress.com/2020/02/22/the-all-powerful-secretary-in-bernie-sanders-medicare-for-all-bill-is-a-former-big-pharma-drug-ceo-lobbyist-political-hack/
“Sir Patrick Vallance FRS FMedSci FRCP is Government Chief Scientific Adviser (GCSA) and Head of the Government Science and Engineering (GSE) profession. His personal research was in the area of diseases of blood vessels and endothelial biology. Patrick was President, R&D at GlaxoSmithKline (GSK) from 2012 until 2017. Prior to this, he was Senior Vice President, Medicines Discovery and Development. He joined the company in May 2006 as Head of Drug Discovery. He was a member of the GSK Board and the Corporate Executive Team. During his period as head of R&D over 14 new medicines were approved for use worldwide, for diseases ranging from cancer to asthma and HIV…” https://www.gov.uk/government/people/patrick-vallance https://archive.li/7P0Jf
“Sir Patrick John Thompson Vallance FRS FMedSci FRCP (born 1960) is a British medical doctor. Since March 2018 he has been the Chief Scientific Adviser to the Government of the United Kingdom. From 2012 to 2018 he served as president of research and development (R&D) at the multinational pharmaceutical company GlaxoSmithKline (GSK).” https://en.wikipedia.org/wiki/Patrick_Vallance
There is talk of triage/age related limitations on access to intensive care discussed here:
“Italian man begs authorities to collect dead sister amid coronavirus lockdown” by Haley Ott Update on March 13, 2020 / 2:44 PM / CBS NEWS https://archive.li/vqQXH
“Coronavirus: Italian doctor describes patients’ last moments
A doctor on the frontline of the battle against the virus says patients are lucid and ask to talk to their loved ones. Saturday 14 March 2020 08:58, UK https://news.sky.com/story/coronavirus-italian-town-turns-chapel-into-mortuary-chamber-as-it-struggles-to-cope-with-deaths-11956870